Indication
Sarcoidosis
Sarcoidosis is a systemic inflammatory disorder of unknown etiology characterized by the formation of noncaseating granulomas in affected tissues. Read more about Sarcoidosis
334 drugs 161 manufacturers
Drugs that treat it
Common Sarcoidosis therapies.
SOLU-MEDROL (methylprednisolone sodium succinate)
METHYLPREDNISOLONE
METHYLPREDNISOLONE
CORTEF (hydrocortisone)
PREDNISOLONE SODIUM PHOSPHATE
CELESTONE (betamethasone)
ORAPRED ODT (prednisolone sodium phosphate)
MILLIPRED (prednisolone)
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonSarcoidosis is a systemic inflammatory disorder of unknown etiology characterized by the formation of noncaseating granulomas in affected tissues.
While it can involve virtually any organ system—including the skin, eyes, heart, liver, and central nervous system—it most commonly targets the respiratory tract, with intrathoracic lymphadenopathy and pulmonary parenchymal infiltration occurring in approximately 90% of cases.
Pathophysiologically, the disease is driven by an exaggerated cellular immune response, involving antigen-presenting cells and helper T lymphocytes, that triggers localized granulomatous inflammation and potential progressive fibrosis.
Clinical presentations vary widely from asymptomatic incidental findings on chest imaging to persistent cough, dyspnea, fatigue, or organ-specific dysfunction, frequently presenting in young to middle-aged adults.
- nih.gov
Sarcoidosis is a systemic inflammatory disorder of unknown etiology characterized by the formation of noncaseating granulomas in affected tissues Pathophysiologically, the disease is driven by an exaggerated cellular immune response, involving antigen-presenting cells and helper T lymphocytes, that triggers localized granulomatous inflammation and potential progressive fibrosis Clinical presentations vary widely from asymptomatic incidental findings on chest imaging to persistent cough, dyspnea,...
- nih.gov
Sarcoidosis is a systemic inflammatory disorder of unknown etiology characterized by the formation of noncaseating granulomas in affected tissues While it can involve virtually any organ system—including the skin, eyes, heart, liver, and central nervous system—it most commonly targets the respiratory tract, with intrathoracic lymphadenopathy and pulmonary parenchymal infiltration occurring in approximately 90% of cases Pathophysiologically, the disease is driven by an exaggerated cellular immune...
- nih.gov
While it can involve virtually any organ system—including the skin, eyes, heart, liver, and central nervous system—it most commonly targets the respiratory tract, with intrathoracic lymphadenopathy and pulmonary parenchymal infiltration occurring in approximately 90% of cases Clinical presentations vary widely from asymptomatic incidental findings on chest imaging to persistent cough, dyspnea, fatigue, or organ-specific dysfunction, frequently presenting in young to middle-aged adults
- nih.gov
Pathophysiologically, the disease is driven by an exaggerated cellular immune response, involving antigen-presenting cells and helper T lymphocytes, that triggers localized granulomatous inflammation and potential progressive fibrosis Clinical presentations vary widely from asymptomatic incidental findings on chest imaging to persistent cough, dyspnea, fatigue, or organ-specific dysfunction, frequently presenting in young to middle-aged adults
Personalize your experience
Follow Sarcoidosis and get updates as they land.
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.